Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
CCAP
Crescent Capital BDC, Inc.
|
$42.4M | $0.46 | -9.28% | 59.5% | $16.08 |
|
ALCY
Alchemy Investments Acquisition Corp. 1
|
-- | -- | -- | -- | -- |
|
ATMC
AlphaTime Acquisition Corp.
|
-- | -- | -- | -- | -- |
|
GRAF
Graf Global Corp.
|
-- | -- | -- | -- | -- |
|
LEGT
Legato Merger Corp. III
|
-- | -- | -- | -- | -- |
|
TBMC
Trailblazer Merger Corp. I
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
CCAP
Crescent Capital BDC, Inc.
|
$14.56 | $16.08 | $538.6M | 14.99x | $0.42 | 11.54% | 3.46x |
|
ALCY
Alchemy Investments Acquisition Corp. 1
|
$12.00 | -- | $50.5M | 73.06x | $0.00 | 0% | -- |
|
ATMC
AlphaTime Acquisition Corp.
|
$15.60 | -- | $39.8M | 152.05x | $0.00 | 0% | -- |
|
GRAF
Graf Global Corp.
|
$10.73 | -- | $308.5M | 35.59x | $0.00 | 0% | -- |
|
LEGT
Legato Merger Corp. III
|
$10.83 | -- | $279.4M | 32.73x | $0.00 | 0% | -- |
|
TBMC
Trailblazer Merger Corp. I
|
$12.10 | -- | $29.7M | 266.34x | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
CCAP
Crescent Capital BDC, Inc.
|
55.07% | 0.090 | 168.67% | 3.38x |
|
ALCY
Alchemy Investments Acquisition Corp. 1
|
79.55% | 0.089 | 3.5% | 0.09x |
|
ATMC
AlphaTime Acquisition Corp.
|
11.55% | 0.256 | 3.42% | 0.00x |
|
GRAF
Graf Global Corp.
|
-- | 0.022 | -- | 0.00x |
|
LEGT
Legato Merger Corp. III
|
-- | -0.016 | -- | -- |
|
TBMC
Trailblazer Merger Corp. I
|
-1177.47% | -0.094 | 25.81% | 0.70x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
CCAP
Crescent Capital BDC, Inc.
|
$27.8M | $21.4M | 2.24% | 4.93% | 58.62% | $18.7M |
|
ALCY
Alchemy Investments Acquisition Corp. 1
|
-- | -$428.1K | -2.87% | -2.98% | -- | -$421.9K |
|
ATMC
AlphaTime Acquisition Corp.
|
-- | $1.5K | 2.28% | 2.45% | -- | $60.9K |
|
GRAF
Graf Global Corp.
|
-- | -$798.2K | 3.79% | 3.79% | -- | -$106.5K |
|
LEGT
Legato Merger Corp. III
|
-- | -$269.1K | 4.1% | 4.1% | -- | -$212.1K |
|
TBMC
Trailblazer Merger Corp. I
|
-- | -$563.8K | -26.31% | -32.93% | -- | -$1.4M |
Alchemy Investments Acquisition Corp. 1 has a net margin of 19.49% compared to Crescent Capital BDC, Inc.'s net margin of --. Crescent Capital BDC, Inc.'s return on equity of 4.93% beat Alchemy Investments Acquisition Corp. 1's return on equity of -2.98%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
CCAP
Crescent Capital BDC, Inc.
|
76.15% | $0.19 | $1.6B |
|
ALCY
Alchemy Investments Acquisition Corp. 1
|
-- | -$0.08 | $2.1M |
Crescent Capital BDC, Inc. has a consensus price target of $16.08, signalling upside risk potential of 11.77%. On the other hand Alchemy Investments Acquisition Corp. 1 has an analysts' consensus of -- which suggests that it could fall by --. Given that Crescent Capital BDC, Inc. has higher upside potential than Alchemy Investments Acquisition Corp. 1, analysts believe Crescent Capital BDC, Inc. is more attractive than Alchemy Investments Acquisition Corp. 1.
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
CCAP
Crescent Capital BDC, Inc.
|
3 | 1 | 0 |
|
ALCY
Alchemy Investments Acquisition Corp. 1
|
0 | 0 | 0 |
Crescent Capital BDC, Inc. has a beta of 0.559, which suggesting that the stock is 44.06% less volatile than S&P 500. In comparison Alchemy Investments Acquisition Corp. 1 has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
Crescent Capital BDC, Inc. has a quarterly dividend of $0.42 per share corresponding to a yield of 11.54%. Alchemy Investments Acquisition Corp. 1 offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Crescent Capital BDC, Inc. pays 84.04% of its earnings as a dividend. Alchemy Investments Acquisition Corp. 1 pays out -- of its earnings as a dividend. Crescent Capital BDC, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
Crescent Capital BDC, Inc. quarterly revenues are $36.4M, which are larger than Alchemy Investments Acquisition Corp. 1 quarterly revenues of --. Crescent Capital BDC, Inc.'s net income of $7.1M is higher than Alchemy Investments Acquisition Corp. 1's net income of -$341.9K. Notably, Crescent Capital BDC, Inc.'s price-to-earnings ratio is 14.99x while Alchemy Investments Acquisition Corp. 1's PE ratio is 73.06x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Crescent Capital BDC, Inc. is 3.46x versus -- for Alchemy Investments Acquisition Corp. 1. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
CCAP
Crescent Capital BDC, Inc.
|
3.46x | 14.99x | $36.4M | $7.1M |
|
ALCY
Alchemy Investments Acquisition Corp. 1
|
-- | 73.06x | -- | -$341.9K |
AlphaTime Acquisition Corp. has a net margin of 19.49% compared to Crescent Capital BDC, Inc.'s net margin of --. Crescent Capital BDC, Inc.'s return on equity of 4.93% beat AlphaTime Acquisition Corp.'s return on equity of 2.45%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
CCAP
Crescent Capital BDC, Inc.
|
76.15% | $0.19 | $1.6B |
|
ATMC
AlphaTime Acquisition Corp.
|
-- | $0.06 | $13.3M |
Crescent Capital BDC, Inc. has a consensus price target of $16.08, signalling upside risk potential of 11.77%. On the other hand AlphaTime Acquisition Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Crescent Capital BDC, Inc. has higher upside potential than AlphaTime Acquisition Corp., analysts believe Crescent Capital BDC, Inc. is more attractive than AlphaTime Acquisition Corp..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
CCAP
Crescent Capital BDC, Inc.
|
3 | 1 | 0 |
|
ATMC
AlphaTime Acquisition Corp.
|
0 | 0 | 0 |
Crescent Capital BDC, Inc. has a beta of 0.559, which suggesting that the stock is 44.06% less volatile than S&P 500. In comparison AlphaTime Acquisition Corp. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
Crescent Capital BDC, Inc. has a quarterly dividend of $0.42 per share corresponding to a yield of 11.54%. AlphaTime Acquisition Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Crescent Capital BDC, Inc. pays 84.04% of its earnings as a dividend. AlphaTime Acquisition Corp. pays out -- of its earnings as a dividend. Crescent Capital BDC, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
Crescent Capital BDC, Inc. quarterly revenues are $36.4M, which are larger than AlphaTime Acquisition Corp. quarterly revenues of --. Crescent Capital BDC, Inc.'s net income of $7.1M is higher than AlphaTime Acquisition Corp.'s net income of $202.1K. Notably, Crescent Capital BDC, Inc.'s price-to-earnings ratio is 14.99x while AlphaTime Acquisition Corp.'s PE ratio is 152.05x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Crescent Capital BDC, Inc. is 3.46x versus -- for AlphaTime Acquisition Corp.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
CCAP
Crescent Capital BDC, Inc.
|
3.46x | 14.99x | $36.4M | $7.1M |
|
ATMC
AlphaTime Acquisition Corp.
|
-- | 152.05x | -- | $202.1K |
Graf Global Corp. has a net margin of 19.49% compared to Crescent Capital BDC, Inc.'s net margin of --. Crescent Capital BDC, Inc.'s return on equity of 4.93% beat Graf Global Corp.'s return on equity of 3.79%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
CCAP
Crescent Capital BDC, Inc.
|
76.15% | $0.19 | $1.6B |
|
GRAF
Graf Global Corp.
|
-- | $0.06 | $232.8M |
Crescent Capital BDC, Inc. has a consensus price target of $16.08, signalling upside risk potential of 11.77%. On the other hand Graf Global Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Crescent Capital BDC, Inc. has higher upside potential than Graf Global Corp., analysts believe Crescent Capital BDC, Inc. is more attractive than Graf Global Corp..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
CCAP
Crescent Capital BDC, Inc.
|
3 | 1 | 0 |
|
GRAF
Graf Global Corp.
|
0 | 0 | 0 |
Crescent Capital BDC, Inc. has a beta of 0.559, which suggesting that the stock is 44.06% less volatile than S&P 500. In comparison Graf Global Corp. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
Crescent Capital BDC, Inc. has a quarterly dividend of $0.42 per share corresponding to a yield of 11.54%. Graf Global Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Crescent Capital BDC, Inc. pays 84.04% of its earnings as a dividend. Graf Global Corp. pays out -- of its earnings as a dividend. Crescent Capital BDC, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
Crescent Capital BDC, Inc. quarterly revenues are $36.4M, which are larger than Graf Global Corp. quarterly revenues of --. Crescent Capital BDC, Inc.'s net income of $7.1M is higher than Graf Global Corp.'s net income of $1.7M. Notably, Crescent Capital BDC, Inc.'s price-to-earnings ratio is 14.99x while Graf Global Corp.'s PE ratio is 35.59x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Crescent Capital BDC, Inc. is 3.46x versus -- for Graf Global Corp.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
CCAP
Crescent Capital BDC, Inc.
|
3.46x | 14.99x | $36.4M | $7.1M |
|
GRAF
Graf Global Corp.
|
-- | 35.59x | -- | $1.7M |
Legato Merger Corp. III has a net margin of 19.49% compared to Crescent Capital BDC, Inc.'s net margin of --. Crescent Capital BDC, Inc.'s return on equity of 4.93% beat Legato Merger Corp. III's return on equity of 4.1%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
CCAP
Crescent Capital BDC, Inc.
|
76.15% | $0.19 | $1.6B |
|
LEGT
Legato Merger Corp. III
|
-- | $0.08 | $210.9M |
Crescent Capital BDC, Inc. has a consensus price target of $16.08, signalling upside risk potential of 11.77%. On the other hand Legato Merger Corp. III has an analysts' consensus of -- which suggests that it could fall by --. Given that Crescent Capital BDC, Inc. has higher upside potential than Legato Merger Corp. III, analysts believe Crescent Capital BDC, Inc. is more attractive than Legato Merger Corp. III.
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
CCAP
Crescent Capital BDC, Inc.
|
3 | 1 | 0 |
|
LEGT
Legato Merger Corp. III
|
0 | 0 | 0 |
Crescent Capital BDC, Inc. has a beta of 0.559, which suggesting that the stock is 44.06% less volatile than S&P 500. In comparison Legato Merger Corp. III has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
Crescent Capital BDC, Inc. has a quarterly dividend of $0.42 per share corresponding to a yield of 11.54%. Legato Merger Corp. III offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Crescent Capital BDC, Inc. pays 84.04% of its earnings as a dividend. Legato Merger Corp. III pays out -- of its earnings as a dividend. Crescent Capital BDC, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
Crescent Capital BDC, Inc. quarterly revenues are $36.4M, which are larger than Legato Merger Corp. III quarterly revenues of --. Crescent Capital BDC, Inc.'s net income of $7.1M is higher than Legato Merger Corp. III's net income of $2M. Notably, Crescent Capital BDC, Inc.'s price-to-earnings ratio is 14.99x while Legato Merger Corp. III's PE ratio is 32.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Crescent Capital BDC, Inc. is 3.46x versus -- for Legato Merger Corp. III. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
CCAP
Crescent Capital BDC, Inc.
|
3.46x | 14.99x | $36.4M | $7.1M |
|
LEGT
Legato Merger Corp. III
|
-- | 32.73x | -- | $2M |
Trailblazer Merger Corp. I has a net margin of 19.49% compared to Crescent Capital BDC, Inc.'s net margin of --. Crescent Capital BDC, Inc.'s return on equity of 4.93% beat Trailblazer Merger Corp. I's return on equity of -32.93%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
CCAP
Crescent Capital BDC, Inc.
|
76.15% | $0.19 | $1.6B |
|
TBMC
Trailblazer Merger Corp. I
|
-- | -$0.82 | -$627.9K |
Crescent Capital BDC, Inc. has a consensus price target of $16.08, signalling upside risk potential of 11.77%. On the other hand Trailblazer Merger Corp. I has an analysts' consensus of -- which suggests that it could fall by --. Given that Crescent Capital BDC, Inc. has higher upside potential than Trailblazer Merger Corp. I, analysts believe Crescent Capital BDC, Inc. is more attractive than Trailblazer Merger Corp. I.
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
CCAP
Crescent Capital BDC, Inc.
|
3 | 1 | 0 |
|
TBMC
Trailblazer Merger Corp. I
|
0 | 0 | 0 |
Crescent Capital BDC, Inc. has a beta of 0.559, which suggesting that the stock is 44.06% less volatile than S&P 500. In comparison Trailblazer Merger Corp. I has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
Crescent Capital BDC, Inc. has a quarterly dividend of $0.42 per share corresponding to a yield of 11.54%. Trailblazer Merger Corp. I offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Crescent Capital BDC, Inc. pays 84.04% of its earnings as a dividend. Trailblazer Merger Corp. I pays out -- of its earnings as a dividend. Crescent Capital BDC, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
Crescent Capital BDC, Inc. quarterly revenues are $36.4M, which are larger than Trailblazer Merger Corp. I quarterly revenues of --. Crescent Capital BDC, Inc.'s net income of $7.1M is higher than Trailblazer Merger Corp. I's net income of -$3.7M. Notably, Crescent Capital BDC, Inc.'s price-to-earnings ratio is 14.99x while Trailblazer Merger Corp. I's PE ratio is 266.34x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Crescent Capital BDC, Inc. is 3.46x versus -- for Trailblazer Merger Corp. I. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
CCAP
Crescent Capital BDC, Inc.
|
3.46x | 14.99x | $36.4M | $7.1M |
|
TBMC
Trailblazer Merger Corp. I
|
-- | 266.34x | -- | -$3.7M |
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.